Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway
Huntington disease (HD) is a brain disorder characterized by the late onset of motor and cognitive symptoms, even though the neurons in the brain begin to suffer dysfunction and degeneration long before symptoms appear. There is currently no cure. Several molecular and developmental effects of HD ha...
Saved in:
Main Authors: | Wojciech J. Szlachcic (Author), Pawel M. Switonski (Author), Wlodzimierz J. Krzyzosiak (Author), Marek Figlerowicz (Author), Maciej Figiel (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
iPSCs: From Bench to Clinical Bed
by: Yujing Li, et al.
Published: (2016) -
The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside
by: Nina Xie, et al.
Published: (2016) -
Microcell-mediated chromosome transfer between non-identical human iPSCs
by: Narumi Uno, et al.
Published: (2024) -
Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs
by: Kosuke Matsuzono, et al.
Published: (2017) -
iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System
by: Andrés Javier Orqueda, et al.
Published: (2016)